Pharmacoepidemiological Research on N-Nitrosodimethylamine-Contaminated Ranitidine Use and Long-Term Cancer Risk: A Population-Based Longitudinal Cohort Study

Association between Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma: A Korean Nationally Representative Cohort Study

(2022) Soungmun Kim et al.   Journal of Clinical Medicine

Risk of Cancer Following the Use of N-Nitrosodimethylamine (NDMA) Contaminated Ranitidine Products: A Nationwide Cohort Study in South Korea

(2021) Hong Jin Yoon et al.   Journal of Clinical Medicine

Exposure to Ranitidine and Risk of Bladder Cancer

(2021) Chris R. Cardwell et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Robust Post-Matching Inference

(2020) Alberto Abadie et al.   JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION

Risk of Cancer in Association with Ranitidine and Nizatidine vs Other H2 Blockers: Analysis of the Japan Medical Data Center Claims Database 2005–2018

(2020) Masao Iwagami et al.   DRUG SAFETY

Ranitidine Use and Cancer Risk: Results from UK Biobank

(2020) Elizabeth D. Kantor et al.   GASTROENTEROLOGY

The Association between Ranitidine Use and Gastrointestinal Cancers

(2020) Gerald McGwin   Cancers

FDA recalls ranitidine medicines over potential cancer causing impurity

(2019) Elisabeth Mahase   BMJ-British Medical Journal

Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B or C

(2018) Wei-Yu Kao et al.   HEPATOLOGY

Long-term proton pump inhibitors and risk of gastric cancer development after treatment forHelicobacter pylori: a population-based study

(2017) Ka Shing Cheung et al.   GUT

Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis

(2016) An Tran-Duy et al.   Clinical Gastroenterology and Hepatology

Dietary Nitrates, Nitrites, and Nitrosamines Intake and the Risk of Gastric Cancer: A Meta-Analysis

(2015) Peng Song et al.   Nutrients

Revisiting the washout period in the incident user study design: why 6–12 months may not be sufficient

(2015) Andrew W Roberts et al.   Journal of Comparative Effectiveness Research

Use of self-controlled designs in pharmacoepidemiology

(2014) J. Hallas et al.   JOURNAL OF INTERNAL MEDICINE

Dietary N-nitroso compounds and risk of colorectal cancer: a case–control study in Newfoundland and Labrador and Ontario, Canada

(2013) Yun Zhu et al.   BRITISH JOURNAL OF NUTRITION

Traceability of Biopharmaceuticals in Spontaneous Reporting Systems: A Cross-Sectional Study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance Databases

(2013) Niels S. Vermeer et al.   DRUG SAFETY

Targeting gut flora to prevent progression of hepatocellular carcinoma

(2012) Marion Darnaud et al.   JOURNAL OF HEPATOLOGY

N-nitroso compounds and cancer incidence: the European Prospective Investigation into Cancer and Nutrition (EPIC)–Norfolk Study

(2011) Yet Hua Loh et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Propensity Score Matching

(2008) Deborah N Peikes et al.   AMERICAN STATISTICIAN